Preferential blockade by clozapine of hyperlocomotion induced by non-competitive NMDA antagonist MK-801

Indian Journal of Physiology and Pharmacology

Volumn 42, Issue 3, 1998, Pages 375-382

  Ninan, I ^a   Kulkarni, S K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Clozapine; Hyperlocomotion; MK 801; Open field test; Stereotypy

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CLOZAPINE; DIZOCILPINE; HALOPERIDOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; SULPIRIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; RAT; STEREOTYPY;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANALYSIS OF VARIANCE; ANIMALS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HALOPERIDOL; HYPERKINESIS; MICE; MICE, INBRED BALB C; N-METHYLASPARTATE; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; STEREOTYPED BEHAVIOR; SULPIRIDE;

EID: 0031660902     PISSN: 00195499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatment resistant schizophrenic: A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1987; 45: 78-796.
2. 4. Neuropsychopharmacology 1992; 7: 261-283.
3. Iverson SD, Singh L, Oles RJ, Preston C, Tricklebank. Psychopharmacological profile of the N-methyl-D-aspartate (NMDA) receptor antagonist, MK-801, In. Domino EF, Karmenka JM, eds. Sigma and phencyclidine-like compounds as molecular probes in biology. NPP Books, Ann Arbor 1988; 373-382.
4. Koek W, Woods JH, Winger GD. MK-801, proposed noncompetitive antagonist of excitatory aminoacid neurotransmission, produces phenycyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. J Pharmacol Exp Ther 1988; 969-978.
5. Koek W, Ornstein P. A simple and rapid method for assessing similarities among directly observable behavioral effects of drugs : PCP-like effects of 2-amino-5-phosphovalerate in rats. Psychopharmacology 1987; 91: 297-301.
6. O'Neill KA, Liebman JM. Unique behavioral effects of the NMDA antagonist, CPP, upon injection in to the medial pre-frontal cortex of rats. Brain Res 1987; 435: 371-376.
7. Hiramatsu M, Cho AK, Nabehima T. Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine. Eur J Pharmacol 1989; 166: 359-366.
8. Carlsson M, Carlsson A. Interactions between glutamatergic and monoaminergic systems within basal ganglia-implications for schizophrenia and Parkinson's disease. Trends Neurosci 1990; 13: 272-276.
9. Carlsson M, Carlsson A. The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice. J Neural Transm 1989; 75: 221-226.
10. Carlsson M, Carlsson A. Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monamine-depleted mice. J Neural Transm 1989; 77: 64-71.
11. Diana G, Sagratella S. Different capability of N-methyl-D-aspartate antagonists to affect locomotor/ exploratory activity of mice in a computerized on-line open field test. Pharmacol Biochem Behav 1994; 48: 291-295.
12. Freed WJ, Weinberger DR, Bing LA, Wyatt RJ. Neuropharmacological studies of phencyclidine (PCP)-induced behavioral stimultion in mice. Psychopharmacology 1980; 71: 291-297.
13. Freed WJ, Bing LA, Wyatt RJ. Effects of neuroleptics on phencyclidine (PCP)-induced locomotor stimulation in mice. Neuropharmacology 1984; 23: 175-181.
14. Tiedke PI, Bischoff C, Schmidt WJ. MK-801-induced stereotypy and its antagonism by neuroleptic drugs. J Neural Transm 1990; 81: 173-182.
15. Corbett R. Clozapine but not haloperidol antagonizes an MK-801 discriminative cue. Pharmacol Biochem Behav 1995; 51: 561-564.
16. Costall B, Naylor RJ. On the mode of action of apomorphine. Eur J Pharmacol 1973; 21: 350-361.
17. Verma A, Kulkarni SK. Differential role of dopamine receptor subtypes in thermoregulation and Stereotypic behaviour in naive and reserpinized rats. Arch Int Pharmacodyn 1993; 324: 17-32.
18. Kulkarni SK, Dandiya PC. On the mechanism of potentiation of amphetamine induced Stereotypic behavior by imipramine. Psychopharmacology 1972; 27: 367-372.
19. 4 receptor with high affinity for the antipsychotic clozapine. Nature 1991; 350: 610-614.
20. 4 receptors elevated in schizophrenia. Nature 1993; 365: 441-445.
21. Ninal I, Kulkarni SK. The antimuscarinic activity of clozapine in rats. Pharm Sci 1996; 2: 427-428.
22. Albeen JHFV, Strijbosch H. Genotype-dependent effects of scopolamine and eserine on exploring behaviour in mice. Psychopharmacologia 1969; 16: 81-88.
23. Bushnell PJ. Effects of scopolamine on locomotor activity and metabolic rate in mice. Pharmacol Biochem Behav 1987; 26: 195-198.
24. Thornbug JE. Moore KE. Inhibition of anticholinergic drug-induced locomotor stimulation in mice by alpha-methyltyrosine. Neuropharmacology 1973; 12: 1179-1185.
25. Pycock C, Milson J, Tarsy D, Marsden CD. The effect of manipulation of cholinergic mechanisms on turning behaviour in mice with unilateral destruction of the nigro-neostriatal dopaminergic system. Neuropharmacology 1978; 17: 175-183.
26. Schotte A, Janssen PFM, Gommeren W, Luyten WHML, Van Compel P, Lesage AS, De Loore K. Leysen JE. Risperidone compared with new and reference antipsychotic drugs: in vitro an in vivo receptor binding. Psychopharmacology 1996; 124: 57-73.
27. 2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition. Psychopharmacology 1989; 98: 45-50.
28. 2 antagonists modulates the effects of D2 dopamine receptor blockade. J Pharmacol Exp Ther 1990; 253: 1162-1170.
29. Laursen AL, Gerlach J. Antipsychotic effect of remoxipride, a new subsituted benzamide with selective antidopaminergic activity. Acta Psychiatr Scand 1986; 73: 17-21.